Telomir Pharmaceuticals (NASDAQ: TELO) announced a breakthrough with its Telomir-1 platform, successfully stabilizing both Silver(I) (Ag+) and highly ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

This study presents an important discovery regarding the diversity and evolution of gall-forming microbial effectors. Supported by convincing computational structural predictions and analyses, the ...

Think your morning routine is helping with weight loss? Think again. These seven “healthy” morning habits could actually be ...

International Stroke Conference of the American Heart Association/American Stroke Association was held from Feb. 5 to 7 in ...

CMRI researchers discovered that DNA repair pathways control how cancer cells die after radiotherapy. Blocking a key repair ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Seek products containing barrier-replenishing compounds like ceramides, which help retain moisture, and anti-inflammatory ...

Given that the role of PRMT1 in metabolic regulation has been well-documented, we then investigated whether PRMT1 is involved in transforming 6133 cells through metabolic reprogramming. To assess this ...

The Life Sciences Research Facility and the Nano Research Facility are home to the university’s Imaging and Flow Cytometry ...

Researchers are delving deeper into the role of leukocyte telomere length as it relates to stroke, dementia, and depression ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...